Genomic features of host adaptation of Campylobacter in low-income settings

低收入环境中弯曲杆菌宿主适应的基因组特征

基本信息

  • 批准号:
    10615827
  • 负责人:
  • 金额:
    $ 17.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT There is strong epidemiologic evidence of human adaption of the zoonotic pathogen Campylobacter. However, the genomic features of such adaptation have not been systematically evaluated. The overall objective of this project is to identify specific genomic features of Campylobacter that are associated with adaptation to the human host with the long-term goal of applying this knowledge to global reference databases to inform host attribution and guide improved disease control measures to reduce the global burden of Campylobacter disease in humans. Our central hypothesis is that in highly endemic settings, long-term exposure has allowed adaptation to the human host, as opposed to the transient infection epidemiology we usually observe with Campylobacter. Previous evidence of human adaption has been previously suggested by prolonged carriage in immunosuppressed patients and that certain Campylobacter lineages associated with human disease and chronic sequelae such as GBS, are rarely found outside the human host. We have identified these observations in two longitudinal cohort studies in the Peruvian Amazon that cumulatively comprise over 1400 child-years of surveillance, 20,000 stool samples and 850 Campylobacter isolates. Specifically, we evidence a) persistent Campylobacter infection and carriage in over 70% of children with complete 0 to 24-month follow-up, b) high-level of C. jejuni strain diversity derived from humans compared to the global collection of clinical genomes, c) high proportion of strains described exclusively in human hosts (such ST-403, ST2802 and ST- 2993), as compared to the global reference collection and d) considerable reduced genome size of human derived C. jejuni genomes compared to the global reference collection. In order to test our hypothesis, we will 1) Identify genomic features of persistent Campylobacter infections in humans, and 2) Determine if spatiotemporally clustered infections represent human to human transmission. The proposed project will unite a highly complementary group of accomplished researchers with expertise in epidemiology, evolutionary biology, Campylobacter genomics, and bioinformatics to inform strategic and targeted disease control interventions for Campylobacter control in an area with one of the highest documented rates of human MDR Campylobacter infection. [The project is innovative in the way it applies microbial GWAS methods to capitalize on an exceptional strain bank derived from well-defined longitudinal cohort studies to efficiently identify host adaptation.] [High quality evidence of human host adaptation generated by this study would be paradigm shifting to strategies used to control Campylobacter and would likely to alter the clinical management of Campylobacter enteritis.]
摘要 有强有力的流行病学证据表明,人类适应了人畜共患病病原体弯曲杆菌。然而, 这种适应的基因组特征还没有得到系统的评估。这样做的总体目标是 项目是确定弯曲杆菌的特定基因组特征,这些特征与适应 人类主持人,长期目标是将这一知识应用于全球参考数据库,以告知主持人 归因于和指导改进的疾病控制措施,以减轻全球弯曲菌的负担 人类的疾病。我们的中心假设是,在高度流行的环境中,长期暴露于 对人类宿主的适应性,而不是我们通常观察到的短暂感染流行病学 弯曲杆菌。此前人类适应的证据曾被认为是通过长时间携带 免疫抑制的患者和某些与人类疾病有关的弯曲杆菌谱系 慢性后遗症,如GBS,在人类宿主之外很少发现。我们已经确定了这些 在秘鲁亚马逊地区进行的两项纵向队列研究中的观察结果,这两项研究累计超过1400项 儿童年监测,20,000份粪便样本和850株弯曲杆菌分离株。具体地说,我们证明了a) 超过70%的儿童持续感染和携带弯曲杆菌,并获得0至24个月的完整随访, B)与全球临床收集的空肠弯曲菌相比,来自人类的高水平空肠弯曲菌菌株多样性 基因组,c)仅在人类宿主中描述的菌株的高比例(如ST-403、ST2802和ST- 2993),与全球参考样本相比,以及d)显著缩小了人类基因组大小 空肠弯曲菌基因组与全球参考文献的比较。为了检验我们的假设,我们将 1)确定人类持续感染弯曲杆菌的基因组特征,以及2)确定 时空聚集性感染代表人与人之间的传播。拟议中的项目将联合起来 一个高度互补的团队,由具有流行病学、进化论专业知识的资深研究人员组成 生物学、弯曲杆菌基因组学和生物信息学,为战略性和针对性的疾病控制提供信息 在人类耐多药率最高的地区进行弯曲杆菌控制的干预措施 弯曲杆菌感染。[该项目的创新之处在于,它应用了微生物GWAS方法来进行资本化 关于从定义明确的纵向队列研究中获得的有效识别宿主的特殊菌株库 适应。][这项研究产生的人类宿主适应的高质量证据将是范例 转向控制弯曲杆菌的策略,可能会改变临床治疗 弯曲杆菌肠炎。]

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margaret N Kosek其他文献

Epidemiology of emShigella/em species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study
儿童中志贺氏菌属物种和血清型的流行病学:MAL-ED 观察性出生队列研究的回顾性亚研究
  • DOI:
    10.1016/j.lanmic.2024.101064
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    20.400
  • 作者:
    Elizabeth T Rogawski McQuade;Jie Liu;Mustafa Mahfuz;Alexandre Havt;Tintu Varghese;Jasmin Shrestha;Furqan Kabir;Pablo Peñataro Yori;Amidou Samie;Queen Saidi;Adil Kalam;Fatima Aziz;Sahrish Muneer;Rashidul Haque;Aldo A M Lima;Maheswari Kalaivanan;Sanjaya Shrestha;Najeeha Talat Iqbal;Zulfiqar Bhutta;Margaret N Kosek;Eric R Houpt
  • 通讯作者:
    Eric R Houpt
Spatiotemporal variation in risk of emShigella/em infection in childhood: a global risk mapping and prediction model using individual participant data
儿童时期志贺氏菌感染风险的时空变化:使用个体参与者数据的全球风险绘图和预测模型
  • DOI:
    10.1016/s2214-109x(22)00549-6
  • 发表时间:
    2023-03-01
  • 期刊:
  • 影响因子:
    18.000
  • 作者:
    Hamada S Badr;Josh M Colston;Nhat-Lan H Nguyen;Yen Ting Chen;Eleanor Burnett;Syed Asad Ali;Ajit Rayamajhi;Syed M Satter;Nguyen Van Trang;Daniel Eibach;Ralf Krumkamp;Jürgen May;Ayola Akim Adegnika;Gédéon Prince Manouana;Peter Gottfried Kremsner;Roma Chilengi;Luiza Hatyoka;Amanda K Debes;Jerome Ateudjieu;Abu S G Faruque;Margaret N Kosek
  • 通讯作者:
    Margaret N Kosek
A cross-sectional study of associations between the sup13/supC-sucrose breath test, the lactulose rhamnose assay, and growth in children at high risk of environmental enteropathy
一项关于¹³C - 蔗糖呼气试验、乳果糖鼠李糖检测与环境性肠病高风险儿童生长发育之间关联的横断面研究
  • DOI:
    10.1016/j.ajcnut.2024.10.001
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Nirupama Shivakumar;Sayeeda Huq;Maribel Paredes-Olortegui;Silvenus Ochieng Konyole;Sarita Devi;Roger Yazbeck;Victor O Owino;Andrew F Brouwer;Margaret N Kosek;Paul Kelly;Douglas J Morrison;Gwenyth O Lee
  • 通讯作者:
    Gwenyth O Lee

Margaret N Kosek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margaret N Kosek', 18)}}的其他基金

Capacity building in climate and health in the Peruvian Amazon
秘鲁亚马逊地区气候和健康方面的能力建设
  • 批准号:
    10838170
  • 财政年份:
    2023
  • 资助金额:
    $ 17.95万
  • 项目类别:
Genomic features of host adaptation of Campylobacter in low-income settings
低收入环境中弯曲杆菌宿主适应的基因组特征
  • 批准号:
    10452900
  • 财政年份:
    2022
  • 资助金额:
    $ 17.95万
  • 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
  • 批准号:
    10371146
  • 财政年份:
    2021
  • 资助金额:
    $ 17.95万
  • 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
  • 批准号:
    10600981
  • 财政年份:
    2021
  • 资助金额:
    $ 17.95万
  • 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
  • 批准号:
    10184256
  • 财政年份:
    2021
  • 资助金额:
    $ 17.95万
  • 项目类别:
RFA-GH-20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
RFA-GH-20-005,在秘鲁进行综合传染病和公共卫生研究
  • 批准号:
    10842492
  • 财政年份:
    2020
  • 资助金额:
    $ 17.95万
  • 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
  • 批准号:
    10259643
  • 财政年份:
    2020
  • 资助金额:
    $ 17.95万
  • 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
  • 批准号:
    10425210
  • 财政年份:
    2020
  • 资助金额:
    $ 17.95万
  • 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
  • 批准号:
    10462449
  • 财政年份:
    2020
  • 资助金额:
    $ 17.95万
  • 项目类别:
Enabling Infectious Disease Research Capacity in the Peruvian Amazon
增强秘鲁亚马逊地区的传染病研究能力
  • 批准号:
    10456387
  • 财政年份:
    2018
  • 资助金额:
    $ 17.95万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 17.95万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了